These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9491834)

  • 1. Role of lipoproteins in the plasma binding of SDZ PSC 833, a novel multidrug resistance-reversing cyclosporin.
    Simon N; Dailly E; Combes O; Malaurie E; Lemaire M; Tillement JP; Urien S
    Br J Clin Pharmacol; 1998 Feb; 45(2):173-5. PubMed ID: 9491834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-dependent brain penetration of SDZ PSC 833, a novel multidrug resistance-reversing cyclosporin, in rats.
    Lemaire M; Bruelisauer A; Guntz P; Sato H
    Cancer Chemother Pharmacol; 1996; 38(5):481-6. PubMed ID: 8765444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of SDZ PSC 833 ([3'-keto-Bmt1]-[Val2]-cyclosporin) on serum protein binding and distribution to blood cells of doxorubicin, vincristine and etoposide in vitro.
    Watanabe T; Iwasaki M; Todaka T; Morikawa H; Ohtawa M
    Anticancer Drugs; 1997 Apr; 8(4):400-4. PubMed ID: 9180396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the interactions of SDZ PSC 833 ([3'-keto-Bmt1]-Val2]-Cyclosporine), a multidrug resistance modulator, with P-glycoprotein.
    Archinal-Mattheis A; Rzepka RW; Watanabe T; Kokubu N; Itoh Y; Combates NJ; Bair KW; Cohen D
    Oncol Res; 1995; 7(12):603-10. PubMed ID: 8704277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of multidrug resistance by SDZ PSC 833, combined with VAD (vincristine, doxorubicin, dexamethasone) in refractory multiple myeloma. A phase I study.
    Sonneveld P; Marie JP; Huisman C; Vekhoff A; Schoester M; Faussat AM; van Kapel J; Groenewegen A; Charnick S; Zittoun R; Löwenberg B
    Leukemia; 1996 Nov; 10(11):1741-50. PubMed ID: 8892677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the Mdr1a P-glycoprotein gene disruption on the tissue distribution of SDZ PSC 833, a multidrug resistance-reversing agent, in mice.
    Desrayaud S; De Lange EC; Lemaire M; Bruelisauer A; De Boer AG; Breimer DD
    J Pharmacol Exp Ther; 1998 May; 285(2):438-43. PubMed ID: 9580581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [SDZ PSC 833: a novel modulator of MDR].
    Covelli A
    Tumori; 1997; 83(5 Suppl):S21-4. PubMed ID: 9446255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoration of taxol sensitivity of multidrug-resistant cells by the cyclosporine SDZ PSC 833 and the cyclopeptolide SDZ 280-446.
    Jachez B; Nordmann R; Loor F
    J Natl Cancer Inst; 1993 Mar; 85(6):478-83. PubMed ID: 8095304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoring uptake and retention of daunorubicin and idarubicin in P170-related multidrug resistance cells by low concentration D-verapamil, cyclosporin-A and SDZ PSC 833.
    Michieli M; Damiani D; Michelutti A; Candoni A; Masolini P; Scaggiante B; Quadrifoglio F; Baccarani M
    Haematologica; 1994; 79(6):500-7. PubMed ID: 7896208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the nonimmunosuppressive cyclosporin analog SDZ PSC-833 on colchicine and doxorubicin biliary secretion by the rat in vivo.
    Speeg KV; Maldonado AL
    Cancer Chemother Pharmacol; 1994; 34(2):133-6. PubMed ID: 7910787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo circumvention of P-glycoprotein-mediated multidrug resistance of tumor cells with SDZ PSC 833.
    Boesch D; Gavériaux C; Jachez B; Pourtier-Manzanedo A; Bollinger P; Loor F
    Cancer Res; 1991 Aug; 51(16):4226-33. PubMed ID: 1678313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dose-finding and pharmacokinetic study of reversal of multidrug resistance with SDZ PSC 833 in combination with doxorubicin in patients with solid tumors.
    Giaccone G; Linn SC; Welink J; Catimel G; Stieltjes H; van der Vijgh WJ; Eeltink C; Vermorken JB; Pinedo HM
    Clin Cancer Res; 1997 Nov; 3(11):2005-15. PubMed ID: 9815591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of cyclosporin G (NVa2 cyclosporin) in blood and plasma.
    Yatscoff RW; Honcharik N; Lukowski M; Thliveris J; Chackowsky P; Faraci C
    Clin Chem; 1993 Feb; 39(2):213-7. PubMed ID: 8432008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The multidrug resistance modulator SDZ PSC 833 is a potent activator of cellular ceramide formation.
    Cabot MC; Han TY; Giuliano AE
    FEBS Lett; 1998 Jul; 431(2):185-8. PubMed ID: 9708899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical multi-drug resistance (MDR): low sensitivity of a P-glycoprotein-expressing human T lymphoblastoid MDR cell line to classical P-glycoprotein-directed resistance-modulating agents.
    Jachez B; Loor F
    Anticancer Drugs; 1993 Dec; 4(6):605-15. PubMed ID: 7905300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the P-glycoprotein inhibitor, SDZ PSC 833, on the blood and brain pharmacokinetics of colchicine.
    Desrayaud S; Guntz P; Scherrmann JM; Lemaire M
    Life Sci; 1997; 61(2):153-63. PubMed ID: 9217274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomal doxorubicin circumvents PSC 833-free drug interactions, resulting in effective therapy of multidrug-resistant solid tumors.
    Krishna R; Mayer LD
    Cancer Res; 1997 Dec; 57(23):5246-53. PubMed ID: 9393743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of multidrug resistance by SDZ PSC 833 in leukemic and solid-tumor-bearing mouse models.
    Watanabe T; Naito M; Oh-hara T; Itoh Y; Cohen D; Tsuruo T
    Jpn J Cancer Res; 1996 Feb; 87(2):184-93. PubMed ID: 8609068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The reversal of multidrug resistance in multicellular tumor spheroids by SDZ PSC 833.
    Ehrlich PH; Moustafa ZA; Archinal-Mattheis AE; Newman MJ; Bair KW; Cohen D
    Anticancer Res; 1997; 17(1A):129-33. PubMed ID: 9066642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in doxorubicin distribution and toxicity in mice pretreated with the cyclosporin analogue SDZ PSC 833.
    Gonzalez O; Colombo T; De Fusco M; Imperatori L; Zucchetti M; D'Incalci M
    Cancer Chemother Pharmacol; 1995; 36(4):335-40. PubMed ID: 7628053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.